Le Lézard
Classified in: Health, Business
Subjects: LIC, CXP

Ivy Rehab Partners with Hilltop Physical Therapy


WHITE PLAINS, N.Y., April 23, 2024 /PRNewswire/ -- Ivy Rehab, a premier provider of outpatient musculoskeletal rehabilitative services and pediatric therapy nationwide, is pleased to announce its partnership with Hilltop Physical Therapy, further solidifying its reach in Virginia.

Hilltop Physical Therapy, renowned for its holistic approach to patient care and commitment to restoring patients to peak performance, joins forces with Ivy Rehab to enhance their service offerings and continue their tradition of exceptional care.

"At Hilltop, we're not just a clinic; we're a catalyst for healthier lifestyles across generations," remarked Kristen Park, owner at Hilltop.

"With Ivy's dedication to prioritizing patient well-being and delivering excellence in rehabilitation services, our decision to align with Ivy reflects a strategic move aimed at preserving our legacy of exceptional care while leveraging resources to further elevate service offerings," added Steve Kang co-owner at Hilltop.

With a focus on cutting-edge techniques scientifically proven to alleviate pain and promote active living, Hilltop's dedicated therapists empower patients to embrace active living.

"This partnership with Hilltop represents Ivy's commitment to delivering unparalleled quality of care and expanding access to physical therapy services for all patients across the country," said Michael Rucker, CEO Ivy Rehab.

Through this dynamic new partnership, Ivy Rehab and Hilltop Physical Therapy are revolutionizing rehabilitative care in Virginia and beyond.

About Ivy Rehab

Founded in 2003, Ivy Rehab is a rapidly growing network of best-in-class outpatient physical, occupational, speech therapy, and ABA clinics throughout the United States. The Ivy Rehab Network is comprised of multiple brands dedicated to providing exceptional care, personalized treatment, and unparalleled outcomes. With the support of leading middle-market private equity firm Waud Capital Partners, Ivy Rehab will continue its strategic growth via the ongoing investment in new partners who embrace a shared mission, vision, and values, and a culture of being "All About the People."

Contact Information:

Ivy Rehab Network
Ivana Alava, Partnership Liaison
[email protected]

SOURCE Ivy Rehab Network


These press releases may also interest you

at 20:26
/C O R R E C T I O N -- Mitsubishi Tanabe Pharma America/
In the news release, Mitsubishi Tanabe Pharma America to Present RADICAVA ORS® (edaravone) Real-World Data at the Professional Society for Health Economics and Outcomes Research 2024 Annual Meeting, issued 03-May-2024 by Mitsubishi Tanabe Pharma...

at 20:00
Affiliated Dermatologists Notifies of Data Security Incident
Affiliated Dermatologists (AD) is providing notice of a recent data security incident. At this time, AD is not aware of any misuse of any personal information in connection with this incident. What Happened? On March 5, 2024, AD detected it was the...

at 19:19
Statement: The Government of Canada provides an update on the Highly Pathogenic Avian Influenza
With recent news of dairy cattle in the United States testing positive for the Highly Pathogenic Avian Influenza (HPAI) and reports of fragments of HPAI detected in pasteurized milk sold in the U.S., we understand that Canadians may be concerned...

at 19:01
Butterfly Medical Welcomes Experienced Urology Executive to its Helm
Butterfly Medical Ltd, an early-stage medical device company focused on alleviating suffering in patients with BPH (Benign Prostatic Hyperplasia), is excited to announce the hiring of Patrick MacCarthy as CEO. ...

at 18:33
BioVaxys Technology Corp. Closes First Tranche of Private Placement
BioVaxys Technology Corp. (FRA: 5LB) (the "Company") is pleased to announce that it has closed the first tranche (the "First Tranche") of its previously announced non-brokered private placement (the "Private Placement") with the issuance of...

at 18:29
FILAMENT HEALTH ANNOUNCES CHANGE TO BOARD OF DIRECTORS
Filament Health Corp. (Cboe CA: FH) ("Filament" or the "Company"), a clinical-stage natural psychedelic drug development company, today announced that Chris Wagner has stepped down from his position as Director on the Company's board of directors...

More news about Health...


News published on and distributed by: